diabetesarab-diabetes.com/assets/docs/pacd22 presentation.pdfpacd historical interest...
TRANSCRIPT
27 – 29 March, 2018
22nd Pan Arab Conference on
Diabetes
Intercontinental City Stars, Cairo, Egypt
www.arab-diabetes.com
Accreditation
The Emory University School of Medicine designates this live activity. Physicians should only claim credit commensurate with the extent of their participation in the activity. The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians
PACD
Historical Interest
Establishments:
The conference established the Arab Diabetes Consensus Group ADCG
ADAC, PACD & ADCG
The American Diabetes Association collaborated with the conference and the Arab Diabetes Consensus Group ADCG in establishing many statements related to the status of diabetes in this area and were published in the ADA journals.
2002 Opening Lecture:
As of the year 2002 , the opening lecture of the conference was actually addressing the American Diabetes Association Clinical Practice Recommendations in the specific years , presented by the ADA President or another speaker from the ADA.
The Start:
The conference started on 1997 and maintained its position as the biggest diabetes event in the Arab countries.
Speakers:
The conference hosted 250+ of the most eminent international speakers along the 21 years.
Participants:
Received 30.000+ participants during the 21 years as this conference is already the biggest one not only in the Arab region but also in the whole Middle East area.
Date
Tuesday 27 March, 2018
Time
12.30 – 2.45 PM
Certificateissued by Barts Hospital , University of London
Mahmoud Ibrahim USA
Special Symposium Barts Hospital , University of London
Chairpersons
David Leslie UK
Jaakko Tuomilehto
Finland
Prevention is the best way to limit the epidemic of diabetes
George Guthrie
United States
Reversal is the best way to limit the epidemic of diabetes
Standl Eberhard
Germany
Metformin - but what next ?
Jason Baker
United States
Positioning new agents to reduce blood
glucose
Special SymposiumBarts Hospital , University of London
Agenda
Management of Type 2 DiabetesDebate : Prevention or Reversal
Anna Solini
Italy
Workshop Diabetes & the Kidney*Early Prediction
*ESRD & Coronary Events*Role of SGLT2s
*Diabetes in the dialysis units
Stefan Soderberg
Italy
Workshop CVD Prevention*Hypertension*Dyslipidaemia*Heart Failure
*New Diabetes Drugs & CVD prevention*Anti platelets
Darin Olson
United StatesWorkshop
Diabetes in the Hospital*Glucose monitoring
*Insulin dosing and delivery*Pre & Postoperative Care
*Nutrition *Infections
Amy Fischl
United States
Workshop Diabetes Education
*Personality needs *BGSM*Diet
*Insulin use*Conversation maps
Agenda
Susan Beginas
United States
WorkshopDiabetes and Lifestyle Medicine
Cate Collings
United States
Sehnaz Karadeniz
TurkeyWorkshop
Diabetes & the Eye*Screening
*Diabetic Retina*Glucose control & retinopathy
*Medications*Photocoagulation
Standl Eberhard
Germany
Keynote Lecture Don’t miss !
Translating results from recent cardiovascular outcome trials into
practical management of patients with type 2 diabetes
Agenda
Peter Gaede
DenmarkLate-Breaking Clinical Trials
*TOSCA*EMPA-REG follow up
*SUSTAIN-6*TANDEM3
*EXSCEL*DEPICT*DEVOTE*FOURIER
Guillermo Umpierrez
United States
Live Streaming Lecture I
ADA Standards of Care 2018
John Buse
United States
Live Streaming Lecture II
CVD Outcome Trials
Robert Henry
United StatesLive Streaming Lecture III
Future Therapy of Type 2 Diabetes
Agenda
01
02
Don’t miss !!Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm..
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes.
Debate
Diabetes and CVD , the situation in Saudi Arabia
Ebtesam Ba Essa - KSA
Lebanese CVD screening programs
Lara Nasreddine - Lebanon
Risk prevalence, Tunisian data
Hanene Chaabani - Tunisia
the CVD status among diabetics in UAE
Abdulrazzaq Almadani - UAE
Diabetes & CVD Arab Perspective CVD among people with diabetes : the situation in the Arab countries
ChairpersonsGeorge Guthrie - USA
Standl Eberhard- Germany
9.00 – 9.20 9.20 -9.40 9.40 - 10.10 10.10 – 10.20 10.20 – 10.40 10.40 – 11.00
Diabetes and the CVD risks , the Jordanian case
Firas Annabi - Jordan Discussion
CVD & Diabetes footprint
Mohsen Ibrahim - Egypt
How & for whom, we should do screening programs?
Soliman Ghareeb - Egypt
Early Glycemic control and CVD outcome
Gamela Nasr - Egypt
Diabetes & CVD Egyptian Perspective Cardiovascular Disease among people with diabetes : Prevention is always better and cost effective than to intervene
( Symposium organized by prevention working group of the Egyptian Society of Cardiology )
ChairpersonKhairy Abdel-Dayem Egypt
9.0 – 9.25 9.25 – 9.50 9.50 – 10.15 10.15 – 10.45 10.45 – 11.00
Management of CV diseases in diabetic patients. Careful look to subgroup analysis in large CV outcome studies
Omar Awwad - Egypt
Discussion
All accepted abstracts will be published in Primary Care Diabetes by ELSERVIER
Abstracts
